Stockscreener 앱 받기
16.85
786.84%
14.95
시간 외 거래:
17.70
0.85
+5.04%
Atyr Pharma Inc 주식(LIFE)의 최신 뉴스
Is aTyr Pharma Inc. stock forming a triangle patternJuly 2025 Catalysts & Safe Capital Preservation Plans - mfd.ru
Is aTyr Pharma Inc backed by strong institutional buyingJuly 2025 WrapUp & Reliable Intraday Trade Plans - baoquankhu1.vn
Aug Update: Does aTyr Pharma Inc. have pricing powerMarket Risk Analysis & Fast Gain Swing Alerts - baoquankhu1.vn
aTyr Pharma, Inc. (NASDAQ:ATYR) Sees Significant Drop in Short Interest - MarketBeat
Fed Meeting: Is Focus Universal Inc currently under institutional pressureWatch List & Low Risk Entry Point Guides - baoquankhu1.vn
Volume Recap: What drives aTyr Pharma Incs stock priceWeekly Stock Recap & AI Powered Market Trend Analysis - baoquankhu1.vn
Is aTyr Pharma (NASDAQ:ATYR) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
aTyr Pharma, Inc. (NASDAQ:ATYR) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
How aTyr Pharma Inc. stock benefits from tech adoptionMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Will aTyr Pharma Inc. stock outperform growth indexesTrade Entry Report & Free Technical Confirmation Trade Alerts - ulpravda.ru
Will aTyr Pharma Inc. stock split attract more investorsJuly 2025 Summary & Long-Term Growth Plans - ulpravda.ru
Aug Chart Watch: How aTyr Pharma Inc. stock benefits from tech adoptionWeekly Stock Recap & Intraday High Probability Alerts - ulpravda.ru
Can aTyr Pharma Inc. (471A) stock sustain breakout momentumDay Trade & Safe Capital Allocation Plans - ulpravda.ru
Aug EndMonth: Will aTyr Pharma Inc. stock split attract more investorsJuly 2025 WrapUp & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
How strong is aTyr Pharma Inc. stock revenue growthPortfolio Return Report & Low Risk Investment Opportunities - ulpravda.ru
aTyr Pharma, Inc. (ATYR) Stock Analysis: Unveiling a 483% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
aTyr Pharma (NASDAQ:ATYR) Stock Price Up 3.1%Still a Buy? - MarketBeat
Will aTyr Pharma Inc. stock attract ESG investorsStock Watchlist Updates & Exceptional Trading Strategies - ulpravda.ru
Will aTyr Pharma Inc. (471A) stock beat Nasdaq index returns2026 world cup usa national team quarterfinals playmakers high defensive line expert forecast preview - Улправда
Class Action Lawsuit Filed: aTyr Pharma, Inc. (ATYR)Join by December 8, 2025Contact Levi & Korsinsky - The National Law Review
Is aTyr Pharma Inc. stock affected by interest rate hikesJuly 2025 Snapshot & Free Safe Entry Trade Signal Reports - Улправда
How aTyr Pharma Inc. stock reacts to inflationary pressures2025 Buyback Activity & Fast Momentum Stock Entry Tips - Улправда
ATyr Pharma, Inc.(NasdaqCM:ATYR) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Will aTyr Pharma Inc. stock remain a Wall Street favorite2025 Top Gainers & Technical Confirmation Alerts - Улправда
Winners Losers: Will aTyr Pharma Inc. stock remain a Wall Street favoriteWeekly Investment Recap & Accurate Entry/Exit Alerts - Улправда
Why analysts raise outlook for aTyr Pharma Inc. (471A) stockExit Point & AI Forecast for Swing Trade Picks - DonanımHaber
Aug Fed Impact: How aTyr Pharma Inc. stock reacts to inflationary pressures2025 Growth vs Value & Daily Market Momentum Tracking - Улправда
Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders - marketscreener.com
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Rating of “Hold” by Brokerages - Defense World
Healthy Upside Potential: Atyr Pharma Inc (ATYR) - Setenews
ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit - Morningstar
ATYR Deadline: ATYR Investors with Losses Have Opportunity to Le - GuruFocus
Investors SueWallSt Over aTyr Pharma, Inc. Stock DropContact Levi & Korsinsky to Join - Louisiana First News
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - galvnews.com
ATYR DEADLINE ALERT: Hagens Berman Alerts aTyr Pharma - GlobeNewswire
ATYR LAWSUIT ALERT: The Gross Law Firm Notifies aTyr Pharma, Inc - GuruFocus
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ATYR LAWSUIT ALERT: The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com
ATyr Pharma, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsATYR - marketscreener.com
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securi - GuruFocus
Levi & Korsinsky Notifies aTyr Pharma, Inc. (ATYR) InvestorsLead Plaintiff Deadline on December 8, 2025 - ACCESS Newswire
ATYR DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - TMX Newsfile
ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - Newsfile
ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, - GlobeNewswire
ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED LAW FIRM, - GlobeNewswire
0.89%
0.10%
자본화:
|
볼륨(24시간):